Why the study?
Does Roux-en-Y gastric bypass surgery improve blood pressure, fasting blood glucose, and lipid profiles in morbidly obese patients?
Population
82 morbidly obese patients (61 women and 21 men)
Comparison
Roux-en-Y gastric bypass surgery (GBP) vs Pre-surgery baseline
Design
Cohort
Follow-up
6 to 12 months
Authors
Loading...
RYGB was associated with short-term weight loss and metabolic gains in morbid obesity; hypothesis-generating and requires RCTs before practice change.
Does Roux-en-Y gastric bypass surgery improve blood pressure, fasting blood glucose, and lipid profiles in morbidly obese patients?
Roux-en-Y gastric bypass surgery significantly improves metabolic risk factors including blood pressure, glucose, and lipids in morbidly obese patients at 6-12 months.
Cowan et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: